Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy.

Touzeau C, Mina R, Quach H, Hungria V, Bhutani D, Chen W, Kumar S, Chaulagain C, Dimopoulos MA, Bahlis NJ, Maral S, van de Donk NWCJ, Schmidt Filho J, Saja K, Teipel R, Ando M, Roeloffzen W, Annibali O, Augustson B, Botta C, Delforge M, Bourgeois E, Buda G, Hus M, Perrot A, Preis M, Beksac M, Pour L, Farmer S, Nunes M, Oriol A, Melchardt T, Hu Y, Flogegård M, Wang D, Pei L, Wroblewski S, Ariës IM, Quijano Cardé NA, Perova T, de Jager T, Yeh TM, Vanquickelberghe V, Shah P, Chastain K, Kobos R, Carson R, Landgren O, MajesTEC-9 Trial Investigators

Open source

DOI
10.1056/nejmoa2603870
Published
2026 Jul 30
Container
The New England journal of medicine
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2603870,
  title = {Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy.},
  author = {Touzeau C and Mina R and Quach H and Hungria V and Bhutani D and Chen W and Kumar S and Chaulagain C and Dimopoulos MA and Bahlis NJ and Maral S and van de Donk NWCJ and Schmidt Filho J and Saja K and Teipel R and Ando M and Roeloffzen W and Annibali O and Augustson B and Botta C and Delforge M and Bourgeois E and Buda G and Hus M and Perrot A and Preis M and Beksac M and Pour L and Farmer S and Nunes M and Oriol A and Melchardt T and Hu Y and Flogegård M and Wang D and Pei L and Wroblewski S and Ariës IM and Quijano Cardé NA and Perova T and de Jager T and Yeh TM and Vanquickelberghe V and Shah P and Chastain K and Kobos R and Carson R and Landgren O and MajesTEC-9 Trial Investigators},
  year = {2026},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2603870},
  url = {https://doi.org/10.1056/nejmoa2603870}
}

RIS

TY  - JOUR
TI  - Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy.
AU  - Touzeau C
AU  - Mina R
AU  - Quach H
AU  - Hungria V
AU  - Bhutani D
AU  - Chen W
AU  - Kumar S
AU  - Chaulagain C
AU  - Dimopoulos MA
AU  - Bahlis NJ
AU  - Maral S
AU  - van de Donk NWCJ
AU  - Schmidt Filho J
AU  - Saja K
AU  - Teipel R
AU  - Ando M
AU  - Roeloffzen W
AU  - Annibali O
AU  - Augustson B
AU  - Botta C
AU  - Delforge M
AU  - Bourgeois E
AU  - Buda G
AU  - Hus M
AU  - Perrot A
AU  - Preis M
AU  - Beksac M
AU  - Pour L
AU  - Farmer S
AU  - Nunes M
AU  - Oriol A
AU  - Melchardt T
AU  - Hu Y
AU  - Flogegård M
AU  - Wang D
AU  - Pei L
AU  - Wroblewski S
AU  - Ariës IM
AU  - Quijano Cardé NA
AU  - Perova T
AU  - de Jager T
AU  - Yeh TM
AU  - Vanquickelberghe V
AU  - Shah P
AU  - Chastain K
AU  - Kobos R
AU  - Carson R
AU  - Landgren O
AU  - MajesTEC-9 Trial Investigators
PY  - 2026
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2603870
UR  - https://doi.org/10.1056/nejmoa2603870
ER  -

APA

C, T., R, M., H, Q., V, H., D, B., W, C., S, K., C, C., MA, D., NJ, B., S, M., NWCJ, V. D. D., J, S. F., K, S., R, T., M, A., W, R., O, A., B, A., C, B., M, D., E, B., G, B., M, H., A, P., M, P., M, B., L, P., S, F., M, N., A, O., T, M., Y, H., M, F., D, W., L, P., S, W., IM, A., NA, Q. C., T, P., T, D. J., TM, Y., V, V., P, S., K, C., R, K., R, C., O, L., & Investigators, M. T. (2026). Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2603870

Source records